Skip to main content

Table 2 Removal capabilities of investigated blood purification device per mediator. Means expressed ± SD

From: In vitro comparison of the adsorption of inflammatory mediators by blood purification devices

 

Mediators

Removal rates (RR%) at 120 min

Control tubing

oXiris

CytoSorb

Toraymyxin

Pro-inflammatory cytokines

IL-3

3.9 (± 1.4)

99.3 (± 0.0)

99.4 (± 0.0)

70.2 (± 11.1)

IP-10

16.6 (± 17.4)

99.3 (± 0.3)

99.1 (± 0.2)

68.6 (± 11.9)

IL-17α

16.7 (± 7.8)

98.7 (± 0.4)

97.6 (± 0.3)

74.0 (± 6.2)

MIP-1α

2.9 (± 3.1)

97.3 (± 0.4)

97.3 (± 0.4)

91.0 (± 0.4)

MIP-1β

4.7 (± 2.9)

91.5 (± 1.2)

92.4 (± 0.0)

70.3 (± 9.0)

HMGB-1

8.4 (± 3.2)

89.5 (± 0.4)

91.8 (± 0.9)

61.5 (± 1.9)

IL-8

4.6 (± 8.0)

100 (± 0.0)

100 (± 0.0)

34.5 (± 13.1)

IFN-γ

7.9 (± 8.8)

99.5 (± 0.3)

95.7 (± 0.6)

37.4 (± 8.3)

Eotaxin

14.3 (± 9.1)

99.1 (± 0.1)

99.0 (± 0.0)

42.2 (± 7.9)

IL-6

5.2 (± 9.3)

93.5 (± 1.4)

99.6 (± 0.1)

41.8 (± 14.6)

MIF

14.3 (± 5.9)

78.0 (± 24.4)

83.0 (± 20.2)

45.1 (± 13.8)

MCP-1

6.0 (± 4.1)

100 (± 0.0)

100 (± 0.0)

11.3 (± 4.4)

TNF-α

11.8 (± 12.5)

90.1 (± 2.2)

98.4 (± 0.2)

17.9 (± 9.2)

IL-1β

8.2 (± 4.5)

86.8 (± 1.0)

97.2 (± 0.0)

15.0 (± 13.3)

Anti-inflammatory cytokines

IL-4

6.1 (± 8.3)

99.9 (± 0.0)

99.9 (± 0.0)

55.9 (± 16.0)

IL-2

1.8 (± 5.0)

99.4 (± 0.2)

99.3 (± 0.3)

61.6 (± 13.6)

IL-10

8.9 (± 7.7)

99.0 (± 0.4)

99.8 (± 0.0)

40.6 (± 14.9)

IL-13

12.2 (± 5.9)

93.5 (± 0.0)

94.2 (± 0.0)

73.7 (± 20.6)

IL-1Ra

11.2 (± 3.6)

90.2 (± 2.8)

92.1 (± 0.0)

35.4 (± 16.2)

IL-12 p70

7.0 (± 7.5)

22.1 (± 4.5)

76.5 (± 2.5)

6.9 (± 8.0)

Complement factors

C3a

14.8 (± 11.5)

96.4 (± 1.2)

98.2 (± 0.2)

67.9 (± 7.5)

C5a

1.3 (± 4.8)

90.7 (± 0.6)

95.7 (± 1.2)

38.8 (± 7.9)

Serine protease

PAI-1

8.5 (± 4.9)

87.9 (± 1.8)

95.5 (± 0.4)

30.9 (± 9.6)

Growth factors

FGF-23

18.3 (± 12.2)

98.7 (± 1.1)

99.4 (± 0.8)

88.4 (± 5.5)

FGF-21

2.9 (± 0.5)

96.0 (± 0.9)

99.9 (± 0.0)

70.9 (± 10.1)

G-CSF

8.1 (± 9.0)

36.0 (± 2.9)

99.4 (± 0.0)

16.9 (± 8.0)

Fluid removal

CRRT

Yes

No

No

  1. Abbreviations: C complement, CRRT continuous renal replacement therapy, FGF fibroblast growth factor, G-CSF granulocyte colony-stimulating factor (glycoprotein), HMGB-1 high-mobility group box 1 protein, IL interleukin, IFN interferon, IP interferon-induced protein, LPS lipopolysaccharide, MCP monocyte chemoattractant protein, MIF macrophage migration inhibitory factor, MIP macrophage inflammatory protein, PAI plasminogen activator inhibitor, SD standard deviation, TNF tumor necrosis factor, Ra receptor agonist, α alpha, β beta, γ gamma